Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTRANSDERMALGeneric

TESTODERM TTS

TESTOSTERONE

Standard Dose
5MG/24HR
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TESTODERM TTS is listed in Drugs@FDA under application 020791 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TESTOSTERONE Form and strength FILM, EXTENDED RELEASE;TRANSDERMAL - 5MG/24HR Sponsor ALZA Submission history Latest submission status date: 2000-10-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview TESTODERM TTS is listed in Drugs@FDA under application 020791 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TESTOSTERONE Form and strength FILM, EXTENDED RELEASE;TRANSDERMAL - 5MG/24HR Sponsor ALZA Submission history Latest submission status date: 2000-10-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.